Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· April 5, 2026

The Two Materials That Predict Freight Demand Both Just Posted Gains. Here Is What February’s Data Is Telling Us.

View original at finance.yahoo.com
The Two Materials That Predict Freight Demand Both Just Posted Gains. Here Is What February’s Data Is Telling Us. Most truckers track spot rates…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Every load of goods that moves through the U.S. freight system sits on a wooden pallet

    60% confidence
  • The pallet PPI shows one of the cleanest pictures of the freight cycle you will find anywhere in government data

    60% confidence
  • When businesses are shipping a lot of goods, they go through a lot of pallets. When they are not shipping much, pallet demand drops off and pallet prices fall

    60% confidence
  • Pallet prices climbed steadily from late 1980s to 2020, reflecting slow and consistent growth in goods movement year over year, with the index starting at roughly 80 in the 1970s and reaching around 200 by 2021

    60% confidence
  • The materials that become the boxes and pallets your freight rides on get made and shipped before the freight itself ever moves, which means the people buying those materials right now are telling you, in advance, how much freight is coming

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com